⌘K

Login Start Free

Home/Insiders/Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

WB

SEC Insider//CIK 0001903360

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

CIK 00019033605 companiesBOSTON, MA

Transactions

12

Companies

5

Filings

5

CIK

0001903360

Recent Transactions

12 trades

Conversion
Metsera, Inc.$MTSR
Series B Preferred Stock
2025-01-30−4,365,079→ 0 total
Conversion
Metsera, Inc.$MTSR
Common Stock
2025-01-30+1,857,699→ 1,857,699 total
Conversion
Upstream Bio, Inc.$UPB
Series B redeemable convertible preferred stock
2024-10-15−852,940→ 0 total
Conversion
Upstream Bio, Inc.$UPB
Common Stock
2024-10-15+894,733→ 894,733 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+1,386,335→ 1,386,335 total
Conversion
MBX Biosciences, Inc.$MBX
Series C Preferred Stock
2024-09-16−4,854,368→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+403,787→ 1,790,122 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Preferred Stock
2024-09-16−16,666,666→ 0 total
Conversion
CARGO Therapeutics, Inc.
Common Stock
2023-11-14+737,000→ 737,000 total
Conversion
CARGO Therapeutics, Inc.
Series A-1 Preferred Stock
2023-11-14−10,000,000→ 0 total
Conversion
RayzeBio, Inc.
Common Stock
2023-09-19+1,557,846→ 1,557,846 total
Conversion
RayzeBio, Inc.
Series D Preferred Stock
2023-09-19−1,557,846→ 0 total

Companies

5

Recent Filings

5

Address

C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET

BOSTON, MA, 02210

View on SEC.gov